Summary of Significant Accounting Policies and Liquidity and Uncertainties (Tables)
|
3 Months Ended |
Mar. 31, 2023 |
| Summary of Significant Accounting Policies [Abstract] |
|
| Schedule of cash and cash equivalents |
| | |
March 31, 2023 | | |
December 31, 2022 | |
| Cash and cash equivalents | |
$ | 25,268,225 | | |
$ | 43,148,323 | |
| Restricted cash | |
| 228,519 | | |
| 226,422 | |
| Total cash, cash equivalents and restricted cash | |
$ | 25,496,744 | | |
$ | 43,374,745 | |
|
| Schedule of marketable securities |
| | |
Amortized
Cost | | |
Gross
Unrealized
Losses | | |
Gross
Unrealized
Gains | | |
Fair Value | |
| March 31, 2023: | |
| | |
| | |
| | |
| |
| Money Market Funds included in Cash Equivalents | |
$ | 8,026,616 | | |
$ | - | | |
$ | 523 | | |
$ | 8,027,139 | |
| U.S. Government Agency Securities | |
| 25,742,953 | | |
| - | | |
| 15,454 | | |
| 25,758,407 | |
| Corporate Securities | |
| 2,690,038 | | |
| (314 | ) | |
| 893 | | |
| 2,690,617 | |
| Commercial Paper | |
| 1,884,234 | | |
| (765 | ) | |
| - | | |
| 1,883,469 | |
| Subtotal | |
| 30,317,225 | | |
| (1,079 | ) | |
| 16,347 | | |
| 30,332,493 | |
| Total March 31, 2023 | |
$ | 38,343,841 | | |
$ | (1,079 | ) | |
$ | 16,870 | | |
$ | 38,359,632 | |
| December 31, 2022: | |
| | | |
| | | |
| | | |
| | |
| Money Market Funds included in Cash Equivalents | |
$ | 7,311,327 | | |
$ | - | | |
$ | 572 | | |
$ | 7,311,899 | |
| U.S. Government Agency Securities | |
| 12,072,127 | | |
| (3,184 | ) | |
| 2,056 | | |
| 12,070,999 | |
| Corporate Securities | |
| 2,684,235 | | |
| (183 | ) | |
| 909 | | |
| 2,684,961 | |
| Commercial Paper | |
| 888,875 | | |
| (773 | ) | |
| - | | |
| 888,102 | |
| Subtotal | |
| 15,645,237 | | |
| (4,140 | ) | |
| 2,965 | | |
| 15,644,062 | |
| Total December 31, 2022 | |
$ | 22,956,564 | | |
$ | (4,140 | ) | |
$ | 3,537 | | |
$ | 22,955,961 | |
|
| Schedule of carrying and fair value of financial assets |
| | |
Carrying Value | | |
Level 1 | | |
Level 2 | | |
Level 3 | |
| March 31, 2023: | |
| | |
| | |
| | |
| |
| Money Market Funds and Cash Equivalents | |
$ | 8,027,139 | | |
$ | 8,027,139 | | |
$ | - | | |
$ | - | |
| U.S. Government Agency Securities | |
| 25,758,407 | | |
| 25,758,407 | | |
| - | | |
| | |
| Corporate Securities | |
| 2,690,617 | | |
| - | | |
| 2,690,617 | | |
| - | |
| Commercial Paper | |
| 1,883,469 | | |
| - | | |
| 1,883,469 | | |
| - | |
| Subtotal | |
| 30,332,493 | | |
| 25,758,407 | | |
| 4,574,086 | | |
$ | - | |
| Total March 31, 2023 | |
$ | 38,359,632 | | |
$ | 33,785,546 | | |
$ | 4,574,086 | | |
$ | - | |
| December 31, 2022: | |
| | | |
| | | |
| | | |
| | |
| Money Market Funds and Cash Equivalents | |
$ | 7,311,899 | | |
$ | 7,311,899 | | |
$ | - | | |
$ | - | |
| U.S. Government Agency Securities | |
| 12,070,999 | | |
| 12,070,999 | | |
| - | | |
| | |
| Corporate Securities | |
| 2,684,961 | | |
| - | | |
| 2,684,961 | | |
| - | |
| Commercial Paper | |
| 888,102 | | |
| - | | |
| 888,102 | | |
| - | |
| Subtotal | |
| 15,644,062 | | |
| 12,070,999 | | |
| 3,573,063 | | |
| - | |
| Total December 31, 2022 | |
$ | 22,955,961 | | |
$ | 19,382,898 | | |
$ | 3,573,063 | | |
$ | - | |
|
| Schedule of anti-dilutive securities excluded from calculation of diluted net loss per share |
| | |
Three Months Ended
March 31, | |
| | |
2023 | | |
2022 | |
| | |
(Number of Shares of Common Stock Issuable) | |
| Series C non-voting preferred stock | |
| 4,000 | | |
| 4,000 | |
| Series E non-voting preferred stock | |
| 391,953 | | |
| 391,953 | |
| Series G non-voting preferred stock | |
| 5,004,069 | | |
| 5,004,069 | |
| Shares issuable for payment of deferred board compensation | |
| 48,909 | | |
| 48,909 | |
| Shares underlying outstanding warrants | |
| - | | |
| 56,455 | |
| Shares underlying outstanding stock options | |
| 6,126,080 | | |
| 4,067,305 | |
| Shares underlying restricted stock units | |
| 207,469 | | |
| - | |
| Total potentially dilutive shares | |
| 11,782,480 | | |
| 9,572,691 | |
|